AI assistant
J.B. Chemicals & Pharmaceuticals Lt — Call Transcript 2024
May 13, 2024
63696_rns_2024-05-13_e7627d6f-dc16-40ba-b957-c6e03f3329e3.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [596 x 140] intentionally omitted <==
May 13, 2024
BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001
BSE Scrip Code: 506943
Stock Symbol: JBCHEPHARM
Dear Sir,
Subject: Investors/analysts call with management
Ref.: Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has scheduled a conference call for investors and analysts on Tuesday, May 21, 2024 at 1.00 p.m. IST to discuss its results and developments for the fourth quarter ended March 31, 2024.
All interested investors/ analysts may join using the following dial-in numbers:
Universal Dial-in Number (India): +91 22 6280 1141/ +91 22 7115 8042
International Numbers
Hong Kong Local Access Number: 800 964 448 Singapore Local Access Number: 800 101 2045 UK Local Access Number: 0 808 101 1573 USA Local Access Number: 1 866 746 2133
The document containing the link for registration and log-in to join the said conference call is attached herewith. Alternatively, the investor/analysts can also log on to the Company’s website www.jbpharma.com to register and join the said conference call.
==> picture [595 x 154] intentionally omitted <==
==> picture [596 x 140] intentionally omitted <==
The schedule of the meeting may change due to exigencies.
We request you to take this on record.
Thanking you,
Yours faithfully,
For J. B. Chemicals & Pharmaceuticals Ltd.
Digitally signed by Sandeep Anil Phadnis DN: c=IN, o=Personal, title=8434, pseudonym=108F69E4E868E4C1147674C13B 2684AC9CDD8E36, Sandeep 2.5.4.20=715f7603f235e5d1d74002aec03d24cf432efd8296e6e1c3c0c80534a90c098e, Anil Phadnis postalCode=411038, st=Maharashtra, serialNumber=CC500FDD638E71336FC58B204E2BA05EA7C4ADE49B8FE438E8F254C300DE C735, cn=Sandeep Anil Phadnis Date: 2024.05.13 17:19:43 +05'30'
Sandeep Phadnis Vice President –Secretarial & Company Secretary
==> picture [595 x 154] intentionally omitted <==
==> picture [195 x 173] intentionally omitted <==
==> picture [104 x 115] intentionally omitted <==
JB Pharma Q4 FY24 Earnings Conference Call on Tuesday, May 21, 2024 at 1:00 PM IST
J B Chemicals and Pharmaceuticals Ltd. (JB Pharma), one of the fastest growing pharmaceutical companies in India, will host a conference call for investors and analysts on Tuesday, May 21, 2024 at 1:00 PM IST to discuss its results and developments for the fourth quarter ended 31[st] March, 2024. The financial results will be announced on the 17[th] of May, 2024.
The senior management of JB Pharma will be present to address the call.
| Details of the conference call are as follows: | ||
|---|---|---|
| Timing | 1:00-2:00 pm IST Tuesday, May 21, 2024 | |
| To enable participants to connect to the conference call without having to wait | ||
| for an operator, please register at the below mentioned link. | ||
| Pre-registration | ||
| You will receive dial in numbers, passcode and a pin for the concall on the | ||
| registered email address provided by you. Kindly dial into the call on the | ||
| Conference Call date and use thepasscode &pin to connect to call. | ||
| Universal Dial-in Number (India) | +91 22 6280 1141 +91 22 7115 8042 |
|
| Hong Kong Local Access Number | 800 964 448 | |
| Singapore Local Access Number | 800 101 2045 | |
| UK Local Access Number | 0 808 101 1573 | |
| USA Local Access Number | 1 866 746 2133 | |
| For further information please contact: | ||
| Narayan Saraf | Jason D’Souza | Siddharth Rangnekar |
| Chief Financial Officer | Executive Vice President | Shruti Joshi |
| JB Pharma | JB Pharma | CDR India |
| Tel: +91 22 2439 5200 / 2439 5500 | Tel: +91 982 021 5005 | Tel: +91 932 174 0537 / 750 656 7349 |
| Email: [email protected] | Email: [email protected] | Email: [email protected] |
| [email protected] |
==> picture [138 x 71] intentionally omitted <==